Open main menu
Search Ctrl + K
Free Trial
Loading...
Bellerophon Therapeutics, Inc.
Watch
Pharmaceutical Preparations
NASDAQ.BLPH
184 Liberty Corner Road, Suite 302, Warren, NJ, 07059
Categorized
Chronological
Ownership by Owner
Insider Transactions
Institutional Owners
Filings by Form Type
Transcripts
Your Highlights
Search Within Documents
Key Exhibits
Articles & Bylaws
Indentures
Material contracts
Plans of Reorganization
Underwriting Agreements
External Links
Google Finance
SEC EDGAR
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Proxies
DEFA14A
Additional Definitive Proxy Soliciting Materials And Rule 14(a)(12) Material.
12 Feb 24
DEFA14A
Additional Definitive Proxy Soliciting Materials And Rule 14(a)(12) Material.
12 Feb 24
DEFA14A
Additional Definitive Proxy Soliciting Materials And Rule 14(a)(12) Material.
03 Jan 24
DEF 14A
Definitive Proxy Statement Provided In Advance Of A Shareholder Meeting.
06 Nov 23
PRE 14A
Preliminary Proxy Statement Not Yet Definitive.
27 Oct 23
DEFA14A
Additional Definitive Proxy Soliciting Materials And Rule 14(a)(12) Material.
28 Apr 23
DEF 14A
Definitive Proxy Statement Provided In Advance Of A Shareholder Meeting.
28 Apr 23
News
8-K
Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers: Compensatory Arrangements Of Certain Officers, Submission Of Matters To A Vote Of Security Holders, Financial Statements And Exhibits
04 Mar 24
8-K
Entry Into A Material Definitive Agreement, Unregistered Sales Of Equity Securities, Material Modifications To Rights Of Security Holders, Amendments To Articles Of Incorporation Or Bylaws; Change In Fiscal Year, Other Events, Financial Statements And Exhibits
30 Jan 24
8-K
Submission Of Matters To A Vote Of Security Holders, Other Events
22 Jan 24
8-K
Submission Of Matters To A Vote Of Security Holders, Other Events
10 Jan 24
8-K
Submission Of Matters To A Vote Of Security Holders, Other Events
12 Dec 23
8-K
Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers: Compensatory Arrangements Of Certain Officers
21 Nov 23
8-K
Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard; Transfer Of Listing, Other Events, Financial Statements And Exhibits
13 Oct 23
Ownership
SC 13G/A
14 Feb 24
SC 13G
26 Jan 24
SC 13D/A
Amended Statement Of Beneficial Ownership Of More Than 5%.
18 Oct 23
SC 13D/A
Amended Statement Of Beneficial Ownership Of More Than 5%.
17 Oct 23
4
Puissance Capital Management Lp
16 Oct 23
4
Cloyd Mary Ann
09 Jun 23
4
Dekker Martin
09 Jun 23
Prospectuses and Registrations
25-NSE
Notification Filed By National Securities Exchanges Of The Removal From Listing And Registration Of Matured, Redeemed Or Retired Securities.
27 Dec 23
S-8 POS
Post-effective Amendment To An S-8 Filing.
16 Oct 23
S-8 POS
Post-effective Amendment To An S-8 Filing.
16 Oct 23
S-8 POS
Post-effective Amendment To An S-8 Filing.
16 Oct 23
S-8 POS
Post-effective Amendment To An S-8 Filing.
16 Oct 23
S-8 POS
Post-effective Amendment To An S-8 Filing.
16 Oct 23
S-8 POS
Post-effective Amendment To An S-8 Filing.
16 Oct 23
Financials
10-Q
Quarterly Filing
14 Nov 23
10-Q
Quarterly Filing
14 Aug 23
10-Q
Quarterly Filing
15 May 23
10-K
Fiscal Year 2022
31 Mar 23
10-Q
Quarterly Filing
14 Nov 22
10-Q
Quarterly Filing
15 Aug 22
10-Q
Quarterly Filing
11 May 22
Other
SCHEDULE 13G
01 Mar 24
SCHEDULE 13G
26 Jan 24
RW
Registration Withdrawal Request.
16 Oct 23
EFFECT
Notice Of Effectiveness For A Previously Filed Sec Document.
09 Jun 23
CORRESP
Correspondence With The Sec.
08 Jun 23
UPLOAD
Letter From The Sec.
07 Jun 23
S-3
Registration Statement Under The Securities Act.
02 Jun 23